Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential

被引:25
作者
Amos, GJ
Abrahamsson, C
Duker, G
Hondeghem, L
Palmer, M
Carlsson, L [1 ]
机构
[1] AstraZeneca R&D, Integrat Pharmacol, S-43183 Molndal, Sweden
[2] HPC NV, Oostende, Belgium
关键词
antiarrhythmic agents; K-channel; long QT syndrome; QT dispersion; ventricular arrhythmias;
D O I
10.1016/S0008-6363(00)00259-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study the blocking effects of H 345/52 on ionic currents of rabbit ventricular myocytes and how these features translate into a proarrhythmic potential. Methods: The single electrode voltage clamp technique was used to study the effects of H 345/52 on the rapid component of the delayed rectifying potassium current, I-Kr, and the L-type calcium current (I-Ca). Differential effects of H 345/52 and almokalant on APD prolongation were studied in a rabbit Purkinje fibre/ventricular muscle preparation. The temporal variability of the action potential duration (APD) and its relation to proarrhythmias was examined in Langendorff-perfused rabbit hearts administered H 345/52 or almokalant. Anaesthetised, methoxamine-sensitised rabbits were used to assess the propensity of intravenous H 345/52 and ibutilide to induce torsades de pointes (TdP). Results: H 345/52 potently blocked I-Kr (IC50 = 40 nM) without consequential use-dependency. The I-Ca was also blocked, but at higher concentrations (IC50 =1.3 muM). Block of I-Ca was markedly frequency-dependent (positive) and influenced by membrane potential, such that H 345/52 was more effective following clamp steps from plateau potentials than from -80 mV. In the Purkinje fibre-ventricular muscle preparation, almokalant prolonged the Purkinje fibre APD preferentially, whereas H 345/52 homogeneously prolonged APD in both tissue types. In the perfused rabbit heart, H 345/52 (1 muM) and almokalant (0.3 muM) prolonged APD to a similar degree but increased the temporal variability of APD differently, from 3+/-0.4 ms in control hearts to 8+/-1.2 ms and to 38+/-7.5 ms (P<0.001 vs. H 345/52), respectively. Unequivocal early after-depolarisations were seen in 5/6 almokalant-perfused hearts but in no heart administered H 345/52 (P<0.05). In anaesthetised rabbits, H 345/52 (17.4 mu mol/kg) or ibutilide (2.6 mu mol/kg maximum), maximally lengthened the QT interval from 133+/-4.5 to 177+/-8.0 ms and from 125+/-5.1 to 166+/-9.3 ms (P<0.001, n=8). However, whereas ibutilide induced TdP in all animals at 0.06+/-0.009 <mu>mol/kg, H 345/52 did not induce TdP (P = 0.0002) at up to 17.4 mu mol/kg. Conclusions: H 345/52 blocks I-Kr with high potency and I-Ca with somewhat lower potency and was found to delay ventricular repolarisation without substantially increasing temporal or spatial dispersion and without inducing early after-depolarisations or TdP. (C) 2001 Elsevier Science BN. All rights reserved.
引用
收藏
页码:351 / 360
页数:10
相关论文
共 21 条
[1]   Lidocaine and nisoldipine attenuate almakolant-induced dispersion of repolarization and early afterdepolarizations in vitro [J].
Abrahamsson, C ;
Carlsson, L ;
Duker, G .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1996, 7 (11) :1074-1081
[2]   ELECTROPHYSIOLOGICAL AND INOTROPIC EFFECTS OF H-234/09 (ALMOKALANT) INVITRO - A COMPARISON WITH 2 OTHER NOVEL-IK BLOCKING-DRUGS, UK-68,798 (DOFETILIDE) AND E-4031 [J].
ABRAHAMSSON, C ;
DUKER, G ;
LUNDBERG, C ;
CARLSSON, L .
CARDIOVASCULAR RESEARCH, 1993, 27 (05) :861-867
[3]   The M cell: Its contribution to the ECG and to normal and abnormal electrical function of the heart [J].
Antzelevitch, C ;
Shimizu, W ;
Yan, GX ;
Sicouri, S ;
Weissenburger, J ;
Nesterenko, VV ;
Burashnikov, A ;
Di Diego, J ;
Saffitz, J ;
Thomas, GP .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (08) :1124-1152
[4]   A PC-BASED ONLINE SYSTEM FOR PHYSIOLOGICAL IN-VIVO AND IN-VITRO EXPERIMENTS [J].
AXENBORG, JE ;
HIRSCH, I .
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1993, 41 (01) :55-67
[5]  
BRIL A, 1995, J PHARMACOL EXP THER, V273, P1264
[6]   PROARRHYTHMIC EFFECTS OF THE CLASS-III AGENT ALMOKALANT - IMPORTANCE OF INFUSION RATE, QT DISPERSION, AND EARLY AFTERDEPOLARIZATIONS [J].
CARLSSON, L ;
ABRAHAMSSON, C ;
ANDERSSON, B ;
DUKER, G ;
SCHILLERLINHARDT, G .
CARDIOVASCULAR RESEARCH, 1993, 27 (12) :2186-2193
[7]   QTU-PROLONGATION AND TORSADES-DE-POINTES INDUCED BY PUTATIVE CLASS-III ANTIARRHYTHMIC AGENTS IN THE RABBIT - ETIOLOGY AND INTERVENTIONS [J].
CARLSSON, L ;
ALMGREN, O ;
DUKER, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (02) :276-285
[8]  
CARMELIET E, 1992, J PHARMACOL EXP THER, V262, P809
[9]   USE-DEPENDENT BLOCK AND USE-DEPENDENT UNBLOCK OF THE DELAYED RECTIFIER K+ CURRENT BY ALMOKALANT IN RABBIT VENTRICULAR MYOCYTES [J].
CARMELIET, E .
CIRCULATION RESEARCH, 1993, 73 (05) :857-868
[10]   Ibutilide - A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation [J].
Foster, RH ;
Wilde, MI ;
Markham, A .
DRUGS, 1997, 54 (02) :312-330